The neurocutaneous syndromes or phakomatoses are a heterogeneous group of congenital disorders primarily involving structures derived from the embryological neuroectoderm. All of the syndromes involve the central nervous system (CNS). Peripheral nerves, skin and other organ systems may also be involved. Twenty to 30 disorders are now classified as neurocutaneous syndromes. This article reviews the intra-cranial imaging features of some of the commonest. Herron, J. et al. (2000). Clinical Radiology 55, 82-98.
Intracranial Manifestations
Optic pathway gliomas are the most common brain abnormality in NF-1 and occur in 30% of cases. These tumours appear as either a focal mass on the optic nerve or as a diffuse enlargement of a long segment [2] . T2W MRI may show high signal (thought to be posterior extension) in the optic chiasm, tracts and radiations (Figs 1, 2) .
These gliomas are most commonly juvenile pilocytic astrocytomas, but other low and higher-grade gliomas occur. The mesencephalic tectum is the commonest site after the optic pathways, and lesions also occur in the brainstem and cerebrum (Figs 3, 4) . Hydrocephalus is not uncommon and may result either from benign acqueductal stenosis or gliomas of the tectum or tegmentum.
Characteristic foci of increased signal intensity are present in about 75% of patients with NF-1. These lesions are usually multiple, show no mass effect or contrast enhancement, and elicit no oedema. They are commonest in the pons, cerebellar white matter, internal capsule and splenium (Figs 1, 4) . They tend to appear at age 3 years, increasing in size and number till age 10/11 years, and then progressively disappear. They are though to represent harmartomas, abnormal glial cells or dysplastic myelination. Follow-up MRI is recommended to differentiate these lesions from low-grade neoplasms [4] . Similar foci of altered signal are seen in globus pallidus, and although these may show a little mass effect and slight hyperintense signal on T1W MRI they are also presumed to be hamartomas [1, 5] .
Other abnormalities include cranial nerve tumours (rarely); bone dysplasias such as sphenoid wing hypoplasia with subsequent pulsating exopthalmos (Fig. 5) ; plexiform neurofibromas (Fig. 5) ; and orbital abnormalities such as bupthalmos (enlargement of the globe due to congenital glaucoma), retinal phakomas and Lisch nodules. Vascular dysplasias due to intimal proliferation can result in stenoses and occlusions. Aneurysms and arterio-venous malformations (AVM) are also described (Fig. 6 ).
Neurofibromatosis Type 2
This disorder is characterized by bilateral vestibular schwannomas. NF-2 is associated with a deletion on chromosome 22, is autosomal dominant and has an incidence of one in 50 000. Cutaneous manifestations are rare.
Intracranial Manifestations
The characteristic lesions are schwannomas of the acoustic and other cranial nerves (particularly V, sometimes X), and meningiomas. The neoplasms tend to arise from the coverings of the brain (Figs 7-10) .
The bilateral vestibular schwannomas ( Fig. 10 ) present in the second and third decade. They may be cystic.
Meningiomas are often multiple and intraventricular and tend to calcify. They are particularly seen in the lateral ventricle. The choroid plexus may enlarge and become calcified (Fig. 10 ).
Other Forms of Neurofibromatosis
Some patients have a syndrome that appears to be an overlap of NF-1 and NF-2, and this NF-3 syndrome is now recognized clinically although the genetics are not fully established. Several other forms of neurofibromatosis have also been described by Riccardi, all of which may present with intracranial lesions [6] .
TUBEROUS SCLEROSIS (BOURNEVILLE'S DISEASE)
Tuberous sclerosis (TS) is a familial multisystem disease. It is an autosomal dominant disorder with low penetrance, variable expressivity and a prevalence of one in 34 000-100 000 [1, 7] . It has been linked to an abnormality on chromosomes 9 and 16 [7] . The classic triad of symptoms described by Volt in 1908 of seizures, mental retardation and adenoma sebaceum is one end of a clinical spectrum and is seen in less than one-third of cases [2] . Criteria for the diagnosis of this disorder have now been established [1] . Radiological criteria are important in establishing this diagnosis and may be manifest earlier than some clinical features [7] .
Intracranial Manifestations
TS derives its name from the cortical hamartomas or tubers seen in the gyri (most commonly of frontal lobe). These lesions are seen in 95% of cases. Some calcify although the proportion that does so has not been established. The number of calcified cortical lesions increases with age, by age 10 50% of TS patients have calcified cortical tubers. On CT the tubers may appear as lucencies in widened gyri in young patients, this becomes more difficult to see with age unless the lesions calcify. MRI detects these lesions well at all ages, again the features change with age ( Fig. 11 ). In neonates, the gyri appear enlarged and hyperintense to the surrounding unmyelinated white matter on T1W images and hypointense to the white matter on T2W MR images. As the white matter myelinates the appearance alters and the lesions are hypointense on T1W and hyperintense on T2W MR, ultimately becoming isointense on T1W images with increasing age. As the lesions calcify they may again show some T1 hyperintensity [1] .
Subependymal nodules or hamartomas are seen in 90% of cases. The majority calcify and are typically found along the ventricular surface of the lateral ventricle in the striothalamic groove between the caudate and the thalamus, just posterior to the foramen of Munro. Less often, they are seen elsewhere in the ventricular system. The imaging characteristics on CT and MR alter with age, showing progressive calcification on CT. On MR, the nodules alter in signal intensity as myelination progresses. They are best seen on T1W MR images. They may show enhancement with intravenous GdDTPA (Fig. 11) .
Giant cell astrocytomas occur in up to 15% of TS patients. They occur at the foramen of Munro and present as enlarging partly calcified masses with associated hydrocephalus (Fig. 12) . Serpentine flow voids due to dilated vessels are seen in onethird. Their appearance varies and neither signal intensity or contrast enhancement can differentiate the tumour from a subependymal nodule -the change in size is most important. Histologically these tumours tend to be astrocytomas.
White matter lesions are seen in 90% of cases. Many of these represent islets of disordered neurones and glial cells. In a recent study, 21% of patients [9] showed linear or curvilinear hyperintensities in the white matter, extending from subependymal nodules to cortical tubers. These are thought to be bands of hypomyelinated disordered or gliotic cells along the linear radial glial-neuronal unit.
Cerebellar white matter lesions occur in 10% of patients.
STURGE WEBER SYNDROME (ENCEPHALOTRIGEMINAL ANGIOMATOSIS)
This is a congenital disorder of vasculature of the face, the choroid of the eye, and the leptomeninges. It occurs sporadically affecting both sexes equally, but familial cases are reported. The facial angioma (port wine naevus) can involve all or part of the face and is present at birth. It does not change with age. In some cases of SWS there is no facial angioma [1] . The original description by Schirmer in 1860 of a naevus in the distribution of the trigeminal nerve with an ipsilateral leptomeningeal abnormality in the occipital region is not characteristic.
The major pathologic abnormality in SWS is a meningeal angioma in the pia mater, possibly due to persistent primordial sinusoidal vascular channels. This leads to a lack of superficial cortical venous drainage resulting in chronic venous hypertension and ischaemia [1, 10] .
Intracranial Manifestations
The leptomeningeal vascular malformation is best seen on contrast-enhanced MRI (Fig. 13) . Other MR findings include low signal on T2W of the affected gyri and adjacent white matter. The aetiology of this signal change is unclear and may be due to calcification, accelerated myelination or increased deoxyhaemoglobin in the capillaries and veins. Many of the other radiological findings result from the venous stasis. These include atrophy of the underlying cortex accompanied by cerebral calcification which is seen from 1 year of age (Fig.  14) . The calcified opposed gyri are seen as parallel tram-track calcification on plain film.
Enlargement and calcification of the choroid plexus ( Fig. 13 ) on the affected side is well documented, and the size of the choroid plexus correlates positively with the extent of leptomeningeal enhancement [11] .
Enlarged vessels can be seen on MRI and CT deep in the hemisphere probably due to enlargement of deep venous vessels as a result of slow flow or thrombosis in the superficial abnormal venous system, and subsequent shunting of blood through deep medullary veins.
Cranial asymmetry can occur due to hemiatrophy, or paradoxically there may be a large hemicranium on the side of the atrophy secondary to associated subdural collections. The Dyke-Davidoff-Maison syndrome is a constellation of calvarial changes which is sometimes seen. It includes skull thickening, pneumatization of the paranasal sinuses, ipsilateral shift of the falx and elevation of the petrous ridge and lesser wing of sphenoid. This picture may also occur with other causes of hemicerebral atrophy [1] .
VON HIPPEL-LINDAU SYNDROME
An autosomal dominant disorder with incomplete penetrance and a genetic defect at chromosome 3p25-p26 [1] .
It is characterized by tumours of the CNS, typically multiple haemangioblastomas and tumours of the abdominal viscera. The haemangioblastomas occur primarily in the cerebellum (65%) brain stem (20%) and spinal cord (15%) [4] . They tend to be sharply demarcated with smooth borders. Two thirds of these lesions are cystic with a solid component or mural nodule [13] (Fig. 15) . The nodule is isointense to brain on T1W MRI and hyperintense on T2W MRI. Flow voids within the nodule due to tumour vessels are common. The cystic component is hyperintense to CSF on T2W MRI and the wall of the cyst rarely enhances. The mural nodule enhances avidly. Solid tumours have intermediate to high signal on T2W MRI and enhance homogenously. Small areas of increased signal on T2W MRI in the white matter are sometimes seen. The exact nature of these lesions is unclear, they may represent subclinical haemangioblastomas, areas of gliosis or dystrophic white matter.
Many other disorders are now classified as neurocutaneous syndromes, however the vast majority of cases continue to be due to above five conditions. MRI is invaluable in diagnosis and shows previously unsuspected lesions. It is helping to increase our understanding of this complex and diverse group of disorders. The issue of screening or long-term follow-up in patients with these syndromes is as yet unresolved. In 1988 Roach [14] addressed the use of screening for neurofibromatosis, but there is no more recent work. He recommended annual 'followup' of these patients, much of which can be clinical or electrophysiological. MRI is now a useful and acceptable tool and it is the practice in our department to examine these patients yearly.
If patients develop new or altered symptomatology, imaging is obtained as appropriate. Genetic assessment and counselling is vital, and may recommend screening of asymptomatic relatives. Griffiths [7] states that diagnosis of TS is readily made on CT imaging although MRI is more sensitive and may be useful for prognosis. Interval imaging to detect change on SENs and the development of giant cell astrocytoma is of limited value, as patient symptomatology determines whether any intervention is needed. Clinical examination of relatives is only minimally less sensitive than radiological screening and far more cost-effective. In VHL patients, screening on an annual basis has been recommended by several groups [12] and this includes enhanced MRI of brain and spine and abdominal CT or ultrasound. The latter is recommended to allow early detection of the potentially life threatening renal and adrenal tumours. Asymptomatic relatives need careful genetic evaluation and dependant on the results of this, some will require annual screening also.
OTHER NEUROCUTANEOUS SYNDROMES
There are two main groups of disorders, the vascular and the melanocytic neurocutaneous syndromes. They include the following: (i) Wyburn-Mason syndrome. This comprises a facial vascular naevus and cerebral arteriovenous malformation which normally involves the visual pathway or the midbrain. The AVMs may be multiple (Fig. 16) .
(ii) Ataxia telangiectasia. An autosomal recessive disorder with an incidence of one in 40 000 [1] . Oculocutaneous telangiectasia and cerebellar ataxia are seen. Cerebellar atrophy is seen affecting particularly the anterior vermis, with atrophy of the dentate and olivary nuclei and degeneration of the posterior columns (Fig. 17) . Haemorrhage can result from rupture of parenchymal telangiectasia, and cerebral infarcts can result from emboli shunted through pulmonary vascular malformations. There is an increased incidence of lymphoma and leukaemia in this condition. In the presence of a family history of a retinal or CNS haemangioblastoma either: One haemangioblastoma Or one visceral lesion such as a renal tumour; pancreatic cyst or tumour; phaeochromocytoma or papillary cystadenoma of the epidydimis
In an isolated case where there is no clear family history: Two or more haemangioblastomas One haemangioblastoma and one visceral manifestation as listed above
